<p>, /PRNewswire/ -- Bronstein, Gewirtz &amp; Grossman, LLC，一家全國知名的投資者權益律師事務所，宣佈已對加拿大帝國商業銀行（&#34;CIBC&#34;）和加拿大皇家銀行（&#34;RBC&#34;）及其經紀交易子公司（統稱為&#34;被告&#34;）提起集體訴訟。該訴訟指控被告通過下達和執行操縱性交易，故意壓低 Quantum Biopharma Ltd.（&#34;Quantum&#34;）（NASDAQ: QNTM）證券的價格，從而欺詐投資者。</p>
<p>本訴訟旨在代表所有在 2021 年 1 月 6 日至 2025 年 10 月 15 日期間（包括這兩個日期）出售 Quantum 證券的個人和實體，向被告索賠，指控其違反聯邦證券法。鼓勵此類投資者通過訪問律師事務所網站 bgandg.com/QNTM 加入此案。</p>
<p><strong>Quantum 案件詳情</strong></p>
<p>投訴書指控，在整個訴訟期間，被告做出了實質性虛假和誤導性陳述，和/或未能披露以下事實：</p>
<p>(1) 被告多次下達數千個虛假賣單，旨在製造 Quantum 股價下跌的虛假印象；</p>
<p>(2) 這些操縱性訂單是經過計算的，確實欺騙或誘使投資者以人為壓低的價格出售其股份；</p>
<p>(3) 在將市場價格壓低後，被告以這些人為壓低的價格購買 Quantum 股票，從中獲利；以及</p>
<p>(4) 由於被告的不當行為，投資者，包括原告，被錯誤誘導以人為壓低的價格出售其股份。</p>
<p><strong>Quantum 投資者接下來該怎麼辦？</strong></p>
<p>集體訴訟已經提起。如果您希望查看投訴書的副本，可以訪問律師事務所網站 bgandg.com/QNTM，或聯繫 Bronstein, Gewirtz &amp; Grossman, LLC 的 Peretz Bronstein 律師或客户關係經理 Nathan Miller，電話 917-590-0911。如果您在 Quantum 中遭受損失，您有直到 2026 年 2 月 23 日的時間請求法院任命您為首席原告。您分享任何賠償的能力並不要求您擔任首席原告。</p>
<p><strong>對 Quantum 投資者沒有費用</strong></p>
<p>我們，Bronstein, Gewirtz &amp; Grossman LLC，以風險代理的方式代表投資者進行集體訴訟。這意味着我們將請求法院報銷我們的支出和律師費用，通常是總賠償金額的一定比例，僅在我們成功的情況下。</p>
<p><strong>為什麼選擇 Bronstein, Gewirtz &amp; Grossman, LLC 進行 Quantum 證券集體訴訟？</strong></p>
<p>Bronstein, Gewirtz &amp; Grossman, LLC 是一家全國知名的律師事務所，代表投資者進行證券欺詐集體訴訟和股東派生訴訟。我們的事務所為全國投資者追回了數億美元的賠償。更多信息請訪問 www.bgandg.com</p>
<p>&#34;我們的業務重點是恢復投資者資本並確保企業問責，這有助於維護市場的基本誠信，&#34;Bronstein, Gewirtz &amp; Grossman, LLC 的創始合夥人 Peretz Bronstein 表示。</p>
<p>請在 LinkedIn、X、Facebook 或 Instagram 上關注我們以獲取更新。</p>
<p><strong>聯繫信息</strong></p>
<p>Peretz Bronstein 律師或 Nathan Miller</p>
<p>Bronstein, Gewirtz &amp; Grossman, LLC</p>
<p>917-590-0911 | [email protected]</p>
<p>律師廣告。</p>
<p>以往的結果並不保證類似的結果。</p>
<p>來源：Bronstein, Gewirtz &amp; Grossman, LLC</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjI2Jk5ld3NJdGVtSWQ9REM1MzM5MyZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMjYxMjAwUFJfTkVXU19VU1BSX19fX19EQzUzMzkz?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjI2Jk5ld3NJdGVtSWQ9REM1MzM5MyZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMjYxMjAwUFJfTkVXU19VU1BSX19fX19EQzUzMzkz"/></p>

QNTM

加拿大帝國商業銀行

<p>Bronstein, Gewirtz & Grossman, LLC 已對加拿大帝國商業銀行和加拿大皇家銀行提起集體訴訟，指控他們操縱交易以壓低 Quantum Biopharma Ltd. 的股價。該訴訟尋求對在 2021 年 1 月 6 日至 2025 年 10 月 15 日期間以低價出售 Quantum 證券的投資者進行賠償。投資者必須在 2026 年 2 月 23 日之前申請主訴人資格。該公司以風險代理費用的方式運營，僅在成功的情況下尋求報酬</p>

<p>, /PRNewswire/ -- Bronstein, Gewirtz &amp; Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Canadian Imperial Bank of Commerce (&#34;CIBC&#34;) and Royal Bank of Canada (&#34;RBC&#34;), and their broker-dealer subsidiaries (together, the &#34;Defendants&#34;). The action alleges that Defendants defrauded investors by placing and executing manipulative trades designed to artificially deflate the price of Quantum Biopharma Ltd. (&#34;Quantum&#34;) (NASDAQ: QNTM) securities.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- Bronstein, Gewirtz &amp; Grossman, LLC，一家全國知名的投資者權益律師事務所，宣佈已對加拿大帝國商業銀行（&#34;CIBC&#34;）和加拿大皇家銀行（&#34;RBC&#34;）及其經紀交易子公司（統稱為&#34;被告&#34;）提起集體訴訟。該訴訟指控被告通過下達和執行操縱性交易，故意壓低 Quantum Biopharma Ltd.（&#34;Quantum&#34;）（NASDAQ: QNTM）證券的價格，從而欺詐投資者。</p>
</div><p>This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that sold Quantum securities between January 6, 2021 and October 15, 2025, both dates inclusive (the &#34;Class Period&#34;). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/QNTM.</p>
<div class="lb-trans"><p>本訴訟旨在代表所有在 2021 年 1 月 6 日至 2025 年 10 月 15 日期間（包括這兩個日期）出售 Quantum 證券的個人和實體，向被告索賠，指控其違反聯邦證券法。鼓勵此類投資者通過訪問律師事務所網站 bgandg.com/QNTM 加入此案。</p>
</div><p><strong>Quantum Case Details</strong></p>
<div class="lb-trans"><p><strong>Quantum 案件詳情</strong></p>
</div><p>The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that:</p>
<div class="lb-trans"><p>投訴書指控，在整個訴訟期間，被告做出了實質性虛假和誤導性陳述，和/或未能披露以下事實：</p>
</div><p>(1) Defendants repeatedly entered thousands of spoofed sell orders designed to create the false appearance that Quantum's stock price was declining;</p>
<div class="lb-trans"><p>(1) 被告多次下達數千個虛假賣單，旨在製造 Quantum 股價下跌的虛假印象；</p>
</div><p>(2) These manipulative orders were calculated to—and did—deceive or induce investors to sell their shares at artificially depressed prices;</p>
<div class="lb-trans"><p>(2) 這些操縱性訂單是經過計算的，確實欺騙或誘使投資者以人為壓低的價格出售其股份；</p>
</div><p>(3) After driving the market price down, Defendants purchased Quantum shares at these artificially deflated levels, positioning themselves to profit from the scheme; and</p>
<div class="lb-trans"><p>(3) 在將市場價格壓低後，被告以這些人為壓低的價格購買 Quantum 股票，從中獲利；以及</p>
</div><p>(4) As a result of Defendants' misconduct, investors, including Plaintiff, were improperly induced into selling their shares at artificially depressed prices.</p>
<div class="lb-trans"><p>(4) 由於被告的不當行為，投資者，包括原告，被錯誤誘導以人為壓低的價格出售其股份。</p>
</div><p><strong>What's Next for Quantum Investors?</strong></p>
<div class="lb-trans"><p><strong>Quantum 投資者接下來該怎麼辦？</strong></p>
</div><p>A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/QNTM. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz &amp; Grossman, LLC at 917-590-0911. If you suffered a loss in Quantum you have until February 23, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.</p>
<div class="lb-trans"><p>集體訴訟已經提起。如果您希望查看投訴書的副本，可以訪問律師事務所網站 bgandg.com/QNTM，或聯繫 Bronstein, Gewirtz &amp; Grossman, LLC 的 Peretz Bronstein 律師或客户關係經理 Nathan Miller，電話 917-590-0911。如果您在 Quantum 中遭受損失，您有直到 2026 年 2 月 23 日的時間請求法院任命您為首席原告。您分享任何賠償的能力並不要求您擔任首席原告。</p>
</div><p><strong>No Cost to Quantum Investors</strong></p>
<div class="lb-trans"><p><strong>對 Quantum 投資者沒有費用</strong></p>
</div><p>We, Bronstein, Gewirtz &amp; Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.</p>
<div class="lb-trans"><p>我們，Bronstein, Gewirtz &amp; Grossman LLC，以風險代理的方式代表投資者進行集體訴訟。這意味着我們將請求法院報銷我們的支出和律師費用，通常是總賠償金額的一定比例，僅在我們成功的情況下。</p>
</div><p><strong>Why Bronstein, Gewirtz &amp; Grossman, LLC for Quantum Securities Class Action?</strong></p>
<div class="lb-trans"><p><strong>為什麼選擇 Bronstein, Gewirtz &amp; Grossman, LLC 進行 Quantum 證券集體訴訟？</strong></p>
</div><p>Bronstein, Gewirtz &amp; Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com</p>
<div class="lb-trans"><p>Bronstein, Gewirtz &amp; Grossman, LLC 是一家全國知名的律師事務所，代表投資者進行證券欺詐集體訴訟和股東派生訴訟。我們的事務所為全國投資者追回了數億美元的賠償。更多信息請訪問 www.bgandg.com</p>
</div><p>&#34;Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace,&#34; said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz &amp; Grossman, LLC.</p>
<div class="lb-trans"><p>&#34;我們的業務重點是恢復投資者資本並確保企業問責，這有助於維護市場的基本誠信，&#34;Bronstein, Gewirtz &amp; Grossman, LLC 的創始合夥人 Peretz Bronstein 表示。</p>
</div><p>Follow us for updates on LinkedIn, X, Facebook, or Instagram.</p>
<div class="lb-trans"><p>請在 LinkedIn、X、Facebook 或 Instagram 上關注我們以獲取更新。</p>
</div><p><strong>Contact Info</strong></p>
<div class="lb-trans"><p><strong>聯繫信息</strong></p>
</div><p>Peretz Bronstein, Esq. or Nathan Miller</p>
<div class="lb-trans"><p>Peretz Bronstein 律師或 Nathan Miller</p>
</div><p>Bronstein, Gewirtz &amp; Grossman, LLC</p>
<div class="lb-trans"><p>Bronstein, Gewirtz &amp; Grossman, LLC</p>
</div><p>917-590-0911 | [email protected]</p>
<div class="lb-trans"><p>917-590-0911 | [email protected]</p>
</div><p>Attorney advertising.</p>
<div class="lb-trans"><p>律師廣告。</p>
</div><p>Prior results do not guarantee similar outcomes.</p>
<div class="lb-trans"><p>以往的結果並不保證類似的結果。</p>
</div><p>SOURCE Bronstein, Gewirtz &amp; Grossman, LLC</p>
<div class="lb-trans"><p>來源：Bronstein, Gewirtz &amp; Grossman, LLC</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjI2Jk5ld3NJdGVtSWQ9REM1MzM5MyZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMjYxMjAwUFJfTkVXU19VU1BSX19fX19EQzUzMzkz" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=DC53393&amp;Transmission_Id=202512261200PR_NEWS_USPR_____DC53393&amp;DateId=20251226"/></p>

Bronstein, Gewirtz & Grossman LLC 敦促 Quantum Biopharma Ltd.的投資者採取行動：已提起集體訴訟，指控投資者受到損害